Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients

Overview of attention for article published in Frontiers in oncology, April 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 29 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 11,786 followers.

Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients https://t.co/EOmRSXYOB8

18 Apr 2022

Reply Repost Favourite

Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients https://t.co/4XO82QgdVB

18 Apr 2022

Reply Repost Favourite

New research: Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients: Background Growing evidence supports the modulatory role of human gut microbiome… https://t.c

01 Apr 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.